# Cardiogenic Shock

Sims Hershey 

---

## Definition

- Impairment of CO due to primary cardiac disorder that
    results in end-organ hypoperfusion and hypoxia
- Mortality of up to 40-50%

## Etiology

- Cardiomyopathic: myocardial infarction with LV dysfunction (most common cause),
    exacerbation of heart failure, PHTN exacerbation, myocarditis, myocardial contusion,
    drug-induced
- Arrhythmic: atrial tachycardias (atrial fibrillation/flutter, AVRT,
    AVNRT), VT/VF, complete heart
    block, 2nd degree heart block
- Mechanical: valvular insufficiency, valvular rupture, papillary muscle rupture, critical
    valvular stenosis, ventricular septal wall defect, ruptured
    ventricular wall aneurysm, atrial myxoma, HOCM 

## Presentation and diagnostic criteria 

- "Cold and wet" - decreased perfusion due to reduced cardiac output
    with pulmonary congestion and/or increased left sided filling
    pressures. May also be "cold and dry" in the setting of normal PCWP
    with low cardiac output.
- Signs of end-organ hypoperfusion - AMS, cold and clammy skin,
    decreased UOP (\<30cc/hr), and elevated lactate (\>2).
- SBP \< 90 mmHg for \>30min or needing vasopressors to achieve this
    goal, usually with narrow pulse pressure
- Initially, SVR is elevated in the s/o hypoperfusion. SVR then
    declines in progressive shock due to vasodilation in the s/o
    systemic inflammation causing elevated NO in the shock state.

## Evaluation

- EKG
- Labs: CBC, CMP, BNP, troponin, lactate
    - Evidence of end organ damage: lactic acidosis, acute kidney injury,
    acute liver injury
- Echocardiogram: assess EF and valves
- LHC If ischemia (see ACS)
- Hemodynamic monitoring via Swan-Ganz or PA catheter:
    - No benefit for general shock but does improve in-hospital mortality
    for those with cardiogenic shock
    - PA catheter hemodynamic profile:
        - Cardiac index \< 2.2, cardiac power \<0.6, SVR 800-1600, SVO2
        \<60%
        - LV-dominant: RA (CVP) \<15, PCWP \>18, PAPi \>1.5 (pulmonary
        artery pulsatility index)
        - RV-dominant: RA \>15, PCWP \<18, PAPi \>1.5
        - Bi-V-dominant: RA \>15, PCWP \>18, PAPi \>1.5
        - PAPi \< 1 indicates that patient will likely need RV support
        - CP \< 0.5 strongest independent hemodynamic correlate of
        mortality in CS
        - See right heart cath section for interpreting PA catheter
        profiles

## Management (medical & mechanical circulatory support)

### Medical management

- Medical management: focus on optimizing preload, afterload, and
    contractility
    - Preload: IV diuresis -- hypotension IMPROVES with diuresis in
    cardiogenic shock
    - Afterload: IV -- nitroglycerine, nitroprusside; PO -- hydralazine,
    isosorbide dinitrate; vasoconstricting pressors (phenylephrine,
    vasopressin) if needing BP support
    - Contractility - Inodilators (increase contractility, decrease
    afterload -- milrinone, dobutamine) or inoconstrictors (increase
    contractility and afterload -- epinephrine, norepinephrine)

### Mechanical circulatory support indications

- Shock refractory to \>1 pressor
- Shock 2/2 MI (physiology: unloads LV, increases systemic perfusion,
    increases myocardial perfusion, and provides hemodynamic support
    during PCI)

Types of mechanical circulatory support (MCS)

<table>
<colgroup>
<col style="width: 6%" />
<col style="width: 25%" />
<col style="width: 22%" />
<col style="width: 22%" />
<col style="width: 23%" />
</colgroup>
<thead>
<tr class="header">
<th></th>
<th>Intra-aortic Balloon Pump</th>
<th>V-A ECMO</th>
<th>Tandem Heart</th>
<th>Impella</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Dynamics</td>
<td>Inflates during diastole, deflates during systole</td>
<td>Blood from femoral vein is oxygenated and pumped to femoral
artery</td>
<td><p>LV: blood aspirated from LA to femoral artery</p>
<p>RV: blood aspirate from RA to PA</p></td>
<td><p>Impella 2.5, 5.0 &amp; CP: Blood aspirated from LV to aortic
root</p>
<p>Impella RP: Blood aspirated from IVC and delivered to PA</p></td>
</tr>
<tr class="even">
<td>Flow</td>
<td>1 LMP</td>
<td>4.5 LPM</td>
<td>4-5 LPM</td>
<td><p>2.5: 2.5 L/min</p>
<p>CP: 3.33 L/min</p>
<p>5.0: 5 L/min</p>
<p>RP: 4 L/min</p></td>
</tr>
<tr class="odd">
<td>Support</td>
<td>LV</td>
<td>BiV</td>
<td>LV, RV, or BiV</td>
<td>LV or RV (RP)</td>
</tr>
<tr class="even">
<td>Effects</td>
<td><p>Reduces afterload</p>
<p>Increases stroke volume (SV)</p>
<p>Increases coronary perfusion</p>
<p>Reduces LV preload and PCWP</p></td>
<td><p>Increases afterload</p>
<p>Reduces SV</p>
<p>Reduces LV preload and PCWP</p>
<p>Improves tissue perfusion</p></td>
<td><p>Increases afterload</p>
<p>Reduces SV</p>
<p>Reduces LV preload and PCWP</p>
<p>Improves tissue perfusion</p></td>
<td><p>Reduces SV</p>
<p>Reduces preload and PCWP</p>
<p>Improves tissue perfusion</p></td>
</tr>
<tr class="odd">
<td>Complications</td>
<td><p>Thrombocytopenia</p>
<p>Thrombosis</p>
<p>Arterial obstruction</p>
<p>Aortic rupture or dissection</p>
<p>Air embolism</p></td>
<td><p>Circuit thrombosis</p>
<p>LV dilation</p>
<p>Hypothermia</p>
<p>Gas embolism</p></td>
<td><p>Tamponade d/t perforation</p>
<p>Thrombosis</p>
<p>Embolism (gas or thrombus)</p>
<p>Arterial Shunt</p></td>
<td><p>Pump migration</p>
<p>Hemolysis</p>
<p>Aortic regurg</p>
<p>LV perf</p>
<p>VT/VF</p></td>
</tr>
</tbody>
</table>

## Possible contraindications to mechanical circulatory support:

- Aortic regurgitation, intracardiac shunt via ASD, VSD, or PFO,
    severe RV dysfunction, LA or ventricular thrombus, aortic
    dissection, uncontrolled sepsis, severe coagulopathy or bleeding
    diathesis

## Daily management of MCS devices:

- Ensure optimal placement of device with daily CXR/Echo

- Anticoagulation (based on device)

- Hematoma monitoring at device site

- Check distal pulses to monitor for limb ischemia
